Clinical Trials Imaging Techniques Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026 Interpretable human physiology and anatomy information plays an important role in both clinical and non-clinical trials for many years. Detecting, preventing and treating various ailments often fosters healthcare trends. Clinical references in terms of clinical imaging provide vital insights about drug effects. Hence clinical trial imaging market is flourishing particularly when it comes to research and drug development organisations. The global clinical trial imaging market is estimated to experience profitable growth during the forecast period from 2019 to 2026 registering global CAGR of 6.5%. Potential upsurge in the number of pharma and biotechnology players, research organizations, increase in aged population with chronic diseases along with favourable R&D investments is expected to drive the growth clinical trial imaging market during the forecast period. Clinical Trails Imaging Market Drivers Overview: 1. Advancement in Imaging Technology Numerous technology patents are being filled in an attempt to improve image capturing and evaluation by core imaging labs in order to speed up the development time for pharmaceutical organisations. Data accuracy, adaptability, consistency and compliance to clinical studies is possible due to the latest image analysis software. Advanced technology along with exceptional computation options enables rapid improvements in collection, assessment and submission of clinical trial data. 2. Emerging Pharmaceutical and Biotechnology Industry Medical imaging experiences fluctuations every now and then, yet numerous pharmaceutical and biotechnology companies continue to emerge. Also increasing investment in R&D for developing and discovering new drugs serves as a key driver in clinical trials imaging market upthrust. 3. Mergers and Acquisitions Not only investments in pharma and biotech firms but also the mergers and acquisitions among medical imaging companies are forging ways to enhance clinical trials imaging market. 4. High-Cost Imaging Systems and Implementation Barriers Adoption of innovative imaging technologies to support clinical trials for medical devices comes at a cost. Latest machinery, their installation, setting up mechanisms to transfer scans to a central location incur a high cost as well as high capital required to run clinical trials. Drug discoveries are augmenting the growth of clinical trials which involves imaging guidance documentation, managing quality assurance, performing quality control on scans received and the organization of independent radiological review and/or image analysis involves experts who need to be paid. These factors can restrain the growth of the market. Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=109&page=requestsample Clinical Trails Imaging Market Report Overview: • Imaging Type Segment o Computed Tomography (CT) Scan o Magnetic Resonance Imaging (MRI) o X-Ray o Ultrasound o Echocardiography • End-Users o Bio-Pharmaceutical companies o Medical Devices Manufacturers o Academic Institutes o CROs i.e Contract Research Organizations o Hospitals o Others (cosmetics and skin care companies) Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=109&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on global clinical trials imaging market by imaging type, end-user and region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1. Introduction 1.1. Scope and Objective 1.2. Assumptions and Acronyms 1.3. Forecast Factors 1.4. Research Methodology 2. Executive Summary 2.1. Industry Cluster Analysis 2.2. Competition Matrix 2.3. Strategies Recommendations 3. Market Definition 3.1. Report Scope (Inclusions & Exclusions) 3.2. Market Segmentation 4. Global Clinical Trials Imaging Techniques Market Overview 4.1. Global Clinical Trials Imaging Techniques Market Revenue (USD Mn) 5. Key Inclusions 5.1. Porter’s Five Force analysis 5.2. Market Dynamics 5.3. Industry Trends 5.4. Regulatory Guidelines 5.5. Opportunities in Clinical Trials Imaging Techniques 6. Competition Dynamics 6.1. Company Share Analysis (2019) 6.2. Top 10 Product Pricing by Region 7. Global Clinical Trials Imaging Techniques Market Revenue (USD Mn), 20192026 by Imaging Type 7.1. Key Market Findings 7.2. Long Term ROI Segments 7.3. Revenue Opportunity Influencing Factors 7.4. Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 20192026 7.4.1 CT 7.4.2 MRI 7.4.3 PET 7.4.4 Ultrasound 7.4.5 Echocardiography 7.4.6 X-Ray 8. Global Clinical Trials Imaging Techniques Market Revenue (USD Mn), 2019-2026 by End User 8.1. Key Market Findings 8.2. Long Term ROI Segments 8.3. Revenue Opportunity Influencing Factors 8.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026 8.4.1 BiopharmaceuticalCompanies 8.4.2 ContractResearch Organization 8.4.3 AcademicInstitutes 8.4.4 Hospitals 8.4.5 Medical DeviceManufactures 8.4.6 AcademicInstitutes 9. Global Clinical Trials Imaging Techniques Market Revenue (USD Mn), 2019-2026 by Region 9.1. Key Market Findings 9.2. Long Term ROI Segments 9.3. Revenue Opportunity Influencing Factors 9.4. Market Revenue (USD Mn) Assessment and Forecast by Region,2026 9.4.1 North America 9.4.2 Latin America 9.4.3 Europe 9.4.4 Asia Pacific 9.4.5 Rest of world 10. North America Clinical Trials Imaging Techniques Market Revenue (US$ Mn), 2019-2026 10.1. Key Market Findings 10.2. Long Term ROI Segments 10.3. Revenue Opportunity Influencing Factors 10.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026 10.4.1 US 10.4.2 Canada 10.5. Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2019-2026 10.5.3 CT 10.5.4 MRI 10.5.5 PET 10.5.6 Ultrasound 10.5.7 Echocardiography 10.5.8 X-Ray 10.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026 10.6.9 Biopharmaceutical Companies 10.6.10 Contract Research Organization 10.6.11 Academic Institutes 10.6.12 Hospitals 10.6.13 Medical Device Manufactures 10.6.14 Academic Institutes 11. Latin America Clinical Trials Imaging Techniques Market Revenue (US$ Mn), 2019-2026 11.1. Key Market Findings 11.2. Long Term ROI Segments 11.3. Revenue Opportunity Influencing Factors 11.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026 11.4.1 Brazil 11.4.2 Mexico 11.4.3 Argentina 11.4.4 Rest of Latin America 11.5. Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2019-2026 11.5.5 CT 11.5.6 MRI 11.5.7 PET 11.5.8 Ultrasound 11.5.9 Echocardiography 11.5.10X-Ray 11.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026 11.6.11Biopharmaceutical Companies 11.6.12 Contract Research Organization 11.6.13 Academic Institutes 11.6.14 Hospitals 11.6.15 Medical Device Manufactures 11.6.16 Academic Institutes 12. Europe America Clinical Trials Imaging Techniques Market Revenue (US$ Mn), 2019-2026 12.1. Key Market Findings 12.2. Long Term ROI Segments 12.3. Revenue Opportunity Influencing Factors 12.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026 12.4.1 Germany 12.4.2 France 12.4.3 Spain 12.4.4 UK 12.4.5 Russia 12.4.6 Poland 12.4.7 Rest of Europe 12.5. Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2019-2026 12.5.8 CT 12.5.9 MRI 12.5.10PET 12.5.11Ultrasound 12.5.12Echocardiography 12.5.13X-Ray 12.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026 12.6.14Biopharmaceutical Companies 12.6.15 Contract Research Organization 12.6.16 Academic Institutes 12.6.17 Hospitals 12.6.18 Medical Device Manufactures 12.6.19 Academic Institutes 13. Asia Pacific America Clinical Trials Imaging Techniques Market Revenue (US$ Mn), 2019-2026 13.1. Key Market Findings 13.2. Long Term ROI Segments 13.3. Revenue Opportunity Influencing Factors 13.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026 13.4.1 Emerging Asia 13.4.1.1 China 13.4.1.2 India 13.4.1.3 ASEAN-5 13.4.1.4 Rest of Emerging Asia 13.4.2 Japan 13.5. Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2019-2026 13.5.3 CT 13.5.4 MRI 13.5.5 PET 13.5.6 Ultrasound 13.5.7 Echocardiography 13.5.8 X-Ray 13.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026 13.6.9 Biopharmaceutical Companies 13.6.10 Contract Research Organization 13.6.11 Academic Institutes 13.6.12 Hospitals 13.6.13 Medical Device Manufactures 13.6.14 Academic Institutes 14. Rest of World America Clinical Trials Imaging Techniques Market Revenue (US$ Mn), 2019-2026 14.1. Key Market Findings 14.2. Long Term ROI Segments 14.3. Revenue Opportunity Influencing Factors 14.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026 14.4.1 Middle East 14.4.2 South Africa 14.4.3 North Africa 14.4.4 Rest of World 14.5. Market Revenue (USD Mn) Assessment and Forecast by Imaging Type, 2019-2026 14.5.5 CT 14.5.6 MRI 14.5.7 PET 14.5.8 Ultrasound 14.5.9 Echocardiography 14.5.10X-Ray 14.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026 14.6.11Biopharmaceutical Companies 14.6.12 Contract Research Organization 14.6.13 Academic Institutes 14.6.14 Hospitals 14.6.15 Medical Device Manufactures 14.6.16 Academic Institutes 15. Company Profiles 15.1. Competition Landscape 15.2. Global Company Share (USD Mn) Overview, 2019 15.3. Company Profiles 15.3.1 GE Healthcare 15.3.1.1 Corporate Overview 15.3.1.2 Financial Performance 15.3.1.3 Peer Comparison & 3C marketing equation 15.3.1.4 Company Strategy & Channel Management 15.3.2 Siemens Healthcare 15.3.2.1 Corporate Overview 15.3.2.2 Financial Performance 15.3.2.3 Peer Comparison & 3C marketing equation 15.3.2.4 Company Strategy & Channel Management 15.3.3 Philips Healthcare 15.3.3.1 Corporate Overview 15.3.3.2 Financial Performance 15.3.3.3 Peer Comparison & 3C marketing equation 15.3.3.4 Company Strategy & Channel Management 15.3.4 Shimadzu Corporation 15.3.4.1 Corporate Overview 15.3.4.2 Financial Performance 15.3.4.3 Peer Comparison & 3C marketing equation 15.3.4.4 Company Strategy & Channel Management 15.3.5 Toshiba Medical Systems Corporation 15.3.5.1 Corporate Overview 15.3.5.2 Financial Performance 15.3.5.3 Peer Comparison & 3C marketing equation 15.3.5.4 Company Strategy & Channel Management 15.3.6 Carestream Health 15.3.6.1 Corporate Overview 15.3.6.2 Financial Performance 15.3.6.3 Peer Comparison & 3C marketing equation 15.3.6.4 Company Strategy & Channel Management 15.3.7 Hitachi Medical Corporation 15.3.7.1 Corporate Overview 15.3.7.2 Financial Performance 15.3.7.3 Peer Comparison & 3C marketing equation 15.3.7.4 Company Strategy & Channel Management 15.3.7.5 16. Research Sources & Primary Verbatim Inquire further details about this report at: sales@futurewiseresearch.com About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: sales@futurewiseresearch.com Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com
Interpretable human physiology and anatomy information plays an important role in both clinical and non-clinical trials for many years. Detecting, preventing and treating various ailments often fosters healthcare trends. Clinical references in terms of clinical imaging provide vital insights about drug effects.
© Copyright 2024 Paperzz